Publications

5901 Results

The fundamentals of multiplicity adjustment in biostatistics

Authors
Izmirlian G;Sirota LA;Berger VW;Kipnis V
Journal / Conference
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):10-13. doi: 10.1093/jncimonographs/lgae050
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID39989036
PMC
PMC11848033

Ag(e)nostic precision oncology therapy approvals across the years

Authors
Kudek MR;Adashek JJ;Kurzrock R
Journal / Conference
Trends Cancer. 2025 Aug;11(8):726-735. doi: 10.1016/j.trecan.2025.04.015. Epub 2025 Jun 5.NIHMS2077750
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID40480903
PMC
PMC12350067

Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globally

Authors
Monge C;Eldridge L;Pearlman PC;Venkatesh V;Tregear M;Loehrer PJ Sr;Galassi A;Gopal S;Ginsburg O
Journal / Conference
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):35-41. doi: 10.1093/jncimonographs/lgae043
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID39989041
PMC
PMC11848040

Nectin-4 expression patterns and therapeutics in oncology

Authors
Nikanjam M;Pérez-Granado J;Gramling M;Larvol B;Kurzrock R
Journal / Conference
Cancer Letters (Cancer Lett) 2025 Jul 10;622:217681. doi: 10.1016/j.canlet.2025.217681. Epub 2025 Apr 8.NIHMS2077640
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID40209851
PMC
PMC12132789

Cracking the resistance code: The molecular reclassification of cancer and precision therapy strategies

Authors
Nikanjam M
Journal / Conference
Semin Cancer Biol. 2025 Dec;117:57-68. doi: 10.1016/j.semcancer.2025.10.004. Epub 2025 Oct 30.NIHMS2120810
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID41175949
PMC
PMC12673920

Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection

Authors
Nishizaki D;Kurzrock R;Adashek JJ;Kim KH;Lim HJ;Nikanjam M;Eskander RN;Fanta PT;Okamura R;Lee S;Sicklick JK;Lippman SM;Kato S
Journal / Conference
NPJ Precis Oncol. 2025 Jul 24;9(1):253. doi: 10.1038/s41698-025-01038-w
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID40707733
PMC
PMC12290096

Pan-Cancer Landscape of B- and T-Lymphocyte Attenuator: Implications for Potential Immunotherapy Combinations

Authors
Nishizaki D;Choi S;Pandya C;Lee S;Pabla S;DePietro P;Jensen TJ;Kurzrock R;Kato S
Journal / Conference
JCO Precis Oncol. 2025 Aug;9:e2500304. doi: 10.1200/PO-25-00304. Epub 2025 Aug 6.NIHMS2093486
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID40768679
PMC
PMC12331147

Personalized N-of-1 Combination Therapies for Advanced Gastrointestinal Stromal Tumors

Authors
Noh S;Sharma AK;Fanta PT;Kato S;Kurzrock R;Sicklick JK
Journal / Conference
JCO Precis Oncol. 2025 Jul;9:e2500066. doi: 10.1200/PO-25-00066. Epub 2025 Jul 23.NIHMS2092363
Year
2025
Research Committee(s)
Gastrointestinal
PMID
PMID40700673
PMC
PMC12313172

On the use of external controls in clinical trials

Authors
Nuño MM;Pugh SL;Ji L;Piao J;Dignam JJ;Steingrimsson JA
Journal / Conference
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):30-34. doi: 10.1093/jncimonographs/lgae046
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID39989040
PMC
PMC11848027

The importance of patient-centered research in oncology clinical trials: motivation for the Monograph series

Authors
Pugh SL;Lee C;Dunn BK;Dignam JJ
Journal / Conference
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):1-2. doi: 10.1093/jncimonographs/lgae052
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID39989042
PMC
PMC11848026